Show Summaries | Hide Summaries
We currently have no Breaking News on this stock.
ISCO vs. ETF Alternatives
International Stem Cell Corporation is focused on the therapeutic applications of human parthenogenetic stem cells (hpSCs) and the development and commercialization of cell-based research and cosmetic products. ISCO's core technology, parthenogenesis, results in the creation of pluripotent human... More
Other News & PR